TY  - CONF
AU  - Calvo-Gutierrez, J.
AU  - Lopez-Medina, C.
AU  - Abalos-Aguilera, M. C.
AU  - Perez-Jimenez, A. B.
AU  - Ruiz-Vilchez, D.
AU  - Pilar, F. U.
AU  - Ortega-Castro, R.
AU  - Escudero-Contreras, A.
AU  - Collantes-Estevez, E.
PY  - 2022
DO  - 10.1136/annrheumdis-2022-eular.3926
SN  - 0003-4967
UR  - http://hdl.handle.net/10668/20109
T2  - Annals of the rheumatic diseases
AB  - In the current situation of the SARS-CoV-2 pandemic, the Spanish Society of Rheumatology recommends vaccination of patients with chronic inflammatory diseases (CID) under treatment with biological DMARDs (bDMARDs). However, the data regarding the...
LA  - en
PB  - Bmj publishing group
KW  - RNA, Viral
KW  - Antirheumatic Agents
KW  - Immunoglobulin G
KW  - Rheumatology
KW  - Spike Glycoprotein, Coronavirus
KW  - SARS-CoV-2
KW  - mRNA vaccines
KW  - Pandemics
KW  - Rheumatology
KW  - Undertreatment
KW  - Vaccination
KW  - Antirheumatic agents
TI  - Evaluation of the efficacy and safety of the sars-cov-2 vaccine in patients with chronic inflammatory diseases treated with biological therapy
TY  - conference output
VL  - 81
ER  -